Our Thesis
Healthcare is entering its third structural transition. The companies
building the next generation of healthtech businesses are being built now and Havilland seeks to invest in them.
Healthcare has never been static
Healthcare has reinvented itself three times in recorded history. Each time, a convergence of social pressure, scientific advance, and political will created a new infrastructure layer. Each time, the companies that built and scaled that infrastructure captured disproportionate returns.
1850S TO 1950S
Public Health
Population-scale intervention through civic infrastructure: sanitation, vaccines, maternity care. A new layer of health value, built from scratch.
Each era created new winners. Each era rewarded those who identified the infrastructure need early and backed the companies capable of building it at scale. We believe the third era will be no different.
1950S TO 2020S
Hospital Health
Clinician-led systems focused on specialisation and treatment. Hospitals, pharmaceuticals, modern medicine. Enormous capital deployed. Enormous returns generated.
2020S ONWARDS
Personalised Health
Distributed, data-driven, patient-enabled care. Prevention, prediction, personalised treatment pathways. The transition is underway. The next
generation of healthcare companies are being built now.
The clinician-centric model cannot scale
Modern health systems face pressures they were never designed to absorb. Rising chronic disease, ageing populations, clinician shortages and constrained budgets are not temporary challenges.
Â
The argument is not that existing systems failed. The context around them has changed faster than their design. The institutions are not broken. They are simply insufficient.
Â
This creates a structural premium for scalable clinical value.
Demand
More chronic conditions and longer lifespans are increasing complexity per patient.
Capacity
Clinician time and institutional throughput remain constrained in many major systems.
Expectation
Patients increasingly expect personalization, speed and measurable outcomes.
Each era rewards those who identify the infrastructure need early and back companies capable of building it at scale.
The Investment
Opportunity
A new generation of healthcare companies is building the systems that allow clinical value to be delivered without proportionate increases in clinician time. AI diagnostics, health data platforms, genomics and remote monitoring are extending the reach of healthcare systems and changing how care is delivered.
These are not incremental improvements. They are the infrastructure of the next era of healthcare delivery. The companies that build and scale them will capture the same structural returns that hospital builders and pharmaceutical manufacturers captured in the previous era.
